National Health Investors (NYSE:NHI) Price Target Cut to $81.00 by Analysts at Truist Financial

National Health Investors (NYSE:NHI) had its target price decreased by Truist Financial from $89.00 to $81.00 in a report released on Friday morning, MarketBeat.com reports. Truist Financial currently has a buy rating on the real estate investment trust’s stock.

Other equities analysts also recently issued research reports about the stock. Wells Fargo & Company dropped their price objective on shares of National Health Investors from $84.00 to $79.00 and set an “equal weight” rating for the company in a research note on Monday, June 1st. Cantor Fitzgerald reiterated an “overweight” rating and set a $94.00 price objective on shares of National Health Investors in a research report on Wednesday, April 22nd. Finally, Weiss Ratings reiterated a “buy (b)” rating on shares of National Health Investors in a report on Friday, March 27th. One investment analyst has rated the stock with a Strong Buy rating, four have assigned a Buy rating and two have given a Hold rating to the company. Based on data from MarketBeat, National Health Investors has a consensus rating of “Moderate Buy” and a consensus price target of $85.33.

National Health Investors Trading Up 0.3%

NHI opened at $72.15 on Friday. National Health Investors has a twelve month low of $67.94 and a twelve month high of $91.38. The company has a debt-to-equity ratio of 0.83, a quick ratio of 8.20 and a current ratio of 8.20. The firm’s fifty day moving average is $77.29 and its two-hundred day moving average is $80.08. The firm has a market cap of $3.50 billion, a PE ratio of 23.27, a price-to-earnings-growth ratio of 3.75 and a beta of 0.52.

National Health Investors (NYSE:NHI) last issued its quarterly earnings data on Monday, May 4th. The real estate investment trust reported $0.82 EPS for the quarter, missing analysts’ consensus estimates of $1.21 by ($0.39). The company had revenue of $115.13 million for the quarter, compared to analyst estimates of $70.22 million. National Health Investors had a return on equity of 9.82% and a net margin of 36.86%.The company’s revenue was up 28.9% on a year-over-year basis. During the same quarter in the previous year, the business earned $1.15 earnings per share. National Health Investors has set its FY 2026 guidance at 4.740-4.790 EPS. Equities research analysts anticipate that National Health Investors will post 5.07 EPS for the current year.

National Health Investors Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, August 7th. Stockholders of record on Tuesday, June 30th will be paid a $0.92 dividend. This represents a $3.68 annualized dividend and a dividend yield of 5.1%. The ex-dividend date is Tuesday, June 30th. National Health Investors’s dividend payout ratio is 118.71%.

Insider Buying and Selling

In related news, CEO D. Eric Mendelsohn acquired 1,500 shares of National Health Investors stock in a transaction dated Friday, June 5th. The shares were purchased at an average price of $68.84 per share, for a total transaction of $103,260.00. Following the completion of the transaction, the chief executive officer directly owned 133,316 shares in the company, valued at approximately $9,177,473.44. This represents a 1.14% increase in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Insiders own 2.70% of the company’s stock.

Hedge Funds Weigh In On National Health Investors

A number of large investors have recently added to or reduced their stakes in the company. International Assets Investment Management LLC purchased a new stake in National Health Investors in the fourth quarter valued at approximately $27,000. EverSource Wealth Advisors LLC increased its stake in shares of National Health Investors by 244.1% in the 2nd quarter. EverSource Wealth Advisors LLC now owns 406 shares of the real estate investment trust’s stock worth $28,000 after acquiring an additional 288 shares during the last quarter. Garton & Associates Financial Advisors LLC purchased a new position in shares of National Health Investors during the 4th quarter worth $33,000. GAMMA Investing LLC boosted its holdings in National Health Investors by 41.8% during the 4th quarter. GAMMA Investing LLC now owns 461 shares of the real estate investment trust’s stock valued at $35,000 after acquiring an additional 136 shares during the period. Finally, Key Capital Management INC purchased a new position in shares of National Health Investors in the 4th quarter valued at about $47,000. 62.51% of the stock is currently owned by institutional investors.

About National Health Investors

National Health Investors, Inc (NYSE: NHI) is a specialized real estate investment trust (REIT) focused on owning and financing high-quality healthcare and senior housing facilities in the United States. The company’s portfolio encompasses a diverse range of properties, including skilled nursing centers, assisted living and memory care communities, behavioral health facilities, dialysis clinics, and medical office buildings. NHI typically enters into long-term net-lease agreements with experienced healthcare operators, providing stable and predictable rental income streams while enabling its tenants to concentrate on delivering quality care.

Since its founding in 1991 and initial public offering later that year, National Health Investors has pursued a disciplined growth strategy centered on strategic acquisitions, joint ventures, and selective development.